Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers von Macha, Sreeraj, PhD, Koenen, Rüdiger, MD, Sennewald, Regina, MD, Schöne, Katja, Dipl-Math, Hummel, Noemi, DrSc, Riedmaier, Stephan, PhD, Woerle, Hans J., MD, Salsali, Afshin, MD, Broedl, Uli C., MD

Volltext

Lack of Clinically Relevant Drug–Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers von Macha, Sreeraj, PhD, Sennewald, Regina, MD, Rose, Peter, MD, Schoene, Katja, Dipl-Math, Pinnetti, Sabine, MD, Woerle, Hans J., MD, Broedl, Uli C., MD

Volltext

Oral bioavailability of dabigatran etexilate (Pradaxa®) after co‐medication with verapamil in healthy subjects von Härtter, Sebastian, Sennewald, Regina, Nehmiz, Gerhard, Reilly, Paul

Volltext

Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers von Härtter, Sebastian, Sennewald, Regina, Schepers, Cornelia, Baumann, Sybille, Fritsch, Holger, Friedman, Jeffrey

Volltext

Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor von Desch, Michael, Wunderlich, Glen, Goettel, Markus, Goetz, Sophia, Liesenfeld, Karl-Heinz, Chan, Tom S., Rosenbrock, Holger, Sennewald, Regina, Link, Jasmin, Keller, Sascha, Wind, Sven

Volltext

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile von Clemens, Andreas, van Ryn, Joanne, Sennewald, Regina, Yamamura, Norio, Stangier, Joachim, Feuring, Martin, Härtter, Sebastian

Volltext